Leandro Boer‐Martins

Serelaxin in Addition to Standard Therapy in Acute Heart Failure: Rationale and Design of the RELAX-AHF-2 Study

John R. Teerlink, Adriaan A. Voors, Piotr Ponikowski et al. · European Journal of Heart Failure · 2017 · 122 citations · Full text

Medicine, Cardiology, Pharmacology +11

Relationship of autonomic imbalance and circadian disruption with obesity and type 2 diabetes in resistant hypertensive patients

Leandro Boer‐Martins, Valéria Nasser Figueiredo, Caroline Demacq et al. · Cardiovascular Diabetology · 2011 · 83 citations · Full text

Medicine, Cardiology, Endocrinology +17

Characteristics of resistant hypertension: ageing, body mass index, hyperaldosteronism, cardiac hypertrophy and vascular stiffness

Luíz Cláudio Martins, Valéria Nasser Figueiredo, Thiago Quinaglia et al. · Journal of Human Hypertension · 2010 · 82 citations

Medicine, Cardiology, Endocrinology +15

Hypoadiponectinemia and aldosterone excess are associated with lack of blood pressure control in subjects with resistant hypertension

Ana PC de Faria, Caroline Demacq, Valéria Nasser Figueiredo et al. · Hypertension Research · 2013 · 49 citations · Full text

Medicine, Cardiology, Endocrinology +13

Effects of serelaxin on the outcome of patients with or without substantial peripheral edema: A subgroup analysis from the RELAX-AHF trial

Claudio Gimpelewicz, Marco Metra, John G.F. Cleland et al. · American Heart Journal · 2017 · 11 citations · Full text

Medicine, Internal Medicine, Pharmacology +6